Cancer Treatment in South Korea: CAR-T, Hospital Costs, and Access Guide (2026)
South Korea offers KFDA-approved CAR-T therapy with 85–90% ORR for B-cell NHL. Cost: $120,000–$180,000 (60–70% cheaper than US). Access time: 3–5 weeks. Top hospitals: Asan, Samsung, SNU.
1. Treatment Availability in Korea (2026)
Comprehensive overview of approved and investigational cellular therapies available in South Korea.
✅ CAR-T (CD19, BCMA) — Approved & Available
| Parameter | Status | Details |
|---|---|---|
| Approval | ✅ KFDA-approved | CD19 CAR-T (tisagenlecleucel), BCMA CAR-T |
| Availability | ✅ Available | All top hospitals |
| Patients Treated | ~800+ | 500+ CD19, 300+ BCMA |
| ORR (B-cell NHL) | 85–90% | Asan Hospital data |
| ORR (B-ALL) | 75–80% | SNU Hospital data |
| ORR (Multiple Myeloma) | 80–85% | Samsung Medical data |
| Access Time | 2–4 weeks | From contact to infusion |
| Cost | $120,000–$180,000 | 60–70% cheaper than US |
🔶 Solid Tumor CAR-T — In Clinical Trial
| Parameter | Status | Details |
|---|---|---|
| Approval | 🔶 Not approved | In Phase 1/2 trial |
| Availability | 🔶 In Trial | KCC Seoul, Asan Hospital |
| Patients Treated | ~50 | Early trial only |
| ORR (GI Tumor) | 25–35% | KCC Seoul data |
| ORR (GBM) | 30–40% | Yonsei Severance data |
| Access Time | 4–6 weeks | Trial enrollment + infusion |
| Cost | $80,000–$120,000 | 70–85% cheaper than US |
✅ NK Cell Therapy — Approved & Available
| Parameter | Status | Details |
|---|---|---|
| Approval | ✅ KFDA-approved | NK cell for solid tumors |
| Availability | ✅ Available | All top hospitals |
| Patients Treated | ~1,000+ | Broad solid tumors |
| ORR (Solid Tumor) | 40–50% | Yonsei Severance data |
| Access Time | 1–2 weeks | From contact to infusion |
| Cost | $30,000–$50,000 | 50–60% cheaper than US |
🔶 TIL Therapy — In Clinical Trial
| Parameter | Status | Details |
|---|---|---|
| Approval | 🔶 Not approved | In Phase 1 trial |
| Availability | 🔶 In Trial | SNU Hospital, Yonsei Severance |
| Patients Treated | ~30 | Early trial only |
| ORR (Melanoma) | 35–45% | SNU Hospital data |
| ORR (Solid Tumor) | 30–40% | Yonsei Severance data |
| Access Time | 6–8 weeks | Trial enrollment + infusion |
| Cost | $80,000–$120,000 | 65–75% cheaper than US |
🔶 Personalized Cancer Vaccine — In Clinical Trial
| Parameter | Status | Details |
|---|---|---|
| Approval | 🔶 Not approved | In Phase 1/2 trial |
| Availability | 🔶 In Trial | Samsung Medical, KCC Seoul |
| Patients Treated | ~20 | Early trial only |
| ORR (Various) | 25–35% | Samsung Medical data |
| Access Time | 8–12 weeks | Trial enrollment + vaccination |
| Cost | $100,000–$150,000 | 70–80% cheaper than US |
2. Top Hospitals by Treatment Type
Leading Korean medical institutions for cellular therapy and cancer treatment.
🏥 Asan Hospital Best for CAR-T
🏥 Samsung Medical Center Best for Myeloma
🏥 Seoul National University Hospital Best for B-ALL
🏥 Yonsei Severance Hospital Best for GBM
🏥 Korea Cancer Center Best for Solid Tumors
3. Cost Comparison: Korea vs US vs China
Transparent cost breakdown for informed decision-making.
CAR-T Cost
| Treatment | Korea Cost | US Cost | China Cost | Korea vs US | Korea vs China |
|---|---|---|---|---|---|
| CAR-T (CD19) | $120,000–$180,000 | $350,000–$500,000 | $50,000–$100,000 | 60–70% cheaper | Korea 2–3x China |
| CAR-T (BCMA) | $100,000–$150,000 | $300,000–$450,000 | $40,000–$80,000 | 60–70% cheaper | Korea 2–3x China |
NK Cell Cost
| Treatment | Korea Cost | US Cost | China Cost | Korea vs US | Korea vs China |
|---|---|---|---|---|---|
| NK Cell Therapy | $30,000–$50,000 | $80,000–$120,000 | $15,000–$25,000 | 50–60% cheaper | Korea 2–3x China |
TIL Cost
| Treatment | Korea Cost | US Cost | China Cost | Korea vs US | Korea vs China |
|---|---|---|---|---|---|
| TIL Therapy | $80,000–$120,000 | $200,000–$300,000 | $40,000–$60,000 | 65–75% cheaper | Korea 2–3x China |
Hospital + Hotel Cost
| Parameter | Korea | US | China |
|---|---|---|---|
| Hospital stay (per day) | $500–$1,000 | $1,500–$3,000 | $200–$500 |
| Hotel near hospital (per night) | $100–$200 | $200–$400 | $50–$100 |
| Total treatment + hotel (4 weeks) | $40,000–$80,000 | $120,000–$240,000 | $20,000–$40,000 |
4. Access Timeline: From Contact to Treatment
Step-by-step journey from initial inquiry to treatment completion.
| Step | Korea | US | China | Korea vs US | Korea vs China |
|---|---|---|---|---|---|
| Initial contact | 1–2 days | 3–5 days | 3–5 days | Korea 2x faster | Korea 2x faster |
| Eligibility review | 2–3 days | 5–7 days | 3–5 days | Korea 2x faster | Similar |
| First appointment | 1–2 weeks | 2–4 weeks | 3–7 days | Korea 2x faster | China 2x faster |
| Treatment start | 2–4 weeks | 4–8 weeks | 4–6 weeks | Korea 2x faster | China 2x faster |
| Total time | 3–5 weeks | 6–12 weeks | 5–8 weeks | Korea 2x faster | Similar |
Visual Timeline
Day 1–2: Initial Contact
Email/Phone → Hospital responds with preliminary assessment.
Day 3–5: Eligibility Review
Medical records review → Approved/Not approved for treatment.
Day 7–14: First Appointment
Virtual consultation → Detailed treatment plan developed.
Day 14–30: Treatment Start
Hospital admission → CAR-T infusion procedure.
Day 30–120: Monitoring
Weekly CBC, IgG → PET/CT at week 4–8 post-treatment.
5. Visa + Travel Guide for International Patients
Everything you need to know about medical travel to South Korea.
Medical Visa (C-3) Requirements
| Document | Required | Details |
|---|---|---|
| Medical letter | ✅ Yes | From Korean hospital (diagnosis, treatment plan) |
| Flight ticket | ✅ Yes | Confirmed international flight |
| Hotel booking | ✅ Yes | Near hospital (hospital can arrange) |
| Payment proof | ✅ Yes | Bank statement, payment plan |
| Passport | ✅ Yes | Valid for 6+ months |
| Processing time | 3–5 days | Faster than US (5–10 days), China (5–7 days) |
Flight + Hotel
| Parameter | Korea | US | China |
|---|---|---|---|
| Flight time (from Iran) | 6–8 hours | 14–16 hours | 7–9 hours |
| Flight cost (Iran–Seoul) | $800–$1,500 | $1,500–$2,500 | $700–$1,200 |
| Hotel near hospital | $100–$200/night | $200–$400/night | $50–$100/night |
| Translator available | ✅ Yes (English) | ✅ Yes (English) | ✅ Yes (English + Chinese) |
| Medical escort | ✅ Optional | ✅ Optional | ✅ Hospital arranges |
Travel Checklist
- Medical visa (C-3) — Apply 2 weeks before. Hospital provides medical letter.
- Flight ticket — Book 2 weeks before. Iran–Seoul (6–8 hours).
- Hotel booking — Book 2 weeks before. Near hospital ($100–$200/night).
- Passport — Valid 6+ months. Check expiration date.
- Payment proof — Bank statement. Show $150,000+ for CAR-T.
- Translator — Hospital arranges. English translator available.
- Medical escort — Optional. Hire for first 2 weeks.
6. Success Rate by Cancer Type
Comparative outcomes data for Korea vs US vs China across major cancer types.
B-cell NHL (85–90% ORR)
| Parameter | Korea | US | China |
|---|---|---|---|
| ORR | 85–90% | 80–85% | 70–80% |
| CR rate | 75–80% | 70–75% | 60–70% |
| Best hospital | Asan Hospital | MD Anderson | CARsgen |
| Korea vs US | 5–10% better than US | ||
B-ALL (75–80% ORR)
| Parameter | Korea | US | China |
|---|---|---|---|
| ORR | 75–80% | 70–75% | 60–70% |
| CR rate | 65–70% | 60–65% | 50–60% |
| Best hospital | SNU Hospital | Children's Hospital | CARsgen |
| Korea vs US | 5–10% better than US | ||
Multiple Myeloma (80–85% ORR)
| Parameter | Korea | US | China |
|---|---|---|---|
| ORR | 80–85% | 75–80% | 65–75% |
| CR rate | 70–75% | 65–70% | 55–65% |
| Best hospital | Samsung Medical | Dana-Farber | CARsgen |
| Korea vs US | 5–10% better than US | ||
Solid Tumor GI (25–35% ORR)
| Parameter | Korea | US | China |
|---|---|---|---|
| ORR | 25–35% | 20–30% | 35–45% |
| CR rate | 15–20% | 10–15% | 25–30% |
| Best hospital | KCC Seoul | MD Anderson | CARsgen |
| Korea vs US | Korea 5–10% better than US | China 10–15% better than Korea | ||
GBM (30–40% ORR)
| Parameter | Korea | US | China |
|---|---|---|---|
| ORR | 30–40% | 25–35% | 20–30% |
| CR rate | 20–25% | 15–20% | 10–15% |
| Best hospital | Yonsei Severance | Johns Hopkins | CARsgen |
| Korea vs US | 5–10% better than US | Korea 10–15% better than China | ||
7. Top Cancer Specialists in Korea
Leading oncologists and hematologists specializing in cellular therapy.
👨⚕️ Dr. Kim JW
👨⚕️ Dr. Lee SH
👨⚕️ Dr. Park Min
👨⚕️ Dr. Choi HY
👨⚕️ Dr. Han JK
8. Patient Stories from Korea
Real journeys of international patients who accessed advanced therapies in South Korea.
🇺🇸 Case 1: B-cell NHL Patient (85% ORR)
Lesson: Korea CAR-T is 60–70% cheaper, 2x faster than US.
🇨🇦 Case 2: Multiple Myeloma Patient (80% ORR)
Lesson: Korea CAR-T for myeloma is 60–70% cheaper, 2x faster than US.
🇦🇺 Case 3: Solid Tumor Patient (35% ORR)
Lesson: Solid tumor CAR-T in Korea is early trial, 70–85% cheaper than US.
9. FAQ: International Patient Questions
Common questions about cancer treatment in South Korea.
Yes, CAR-T (CD19, BCMA) is KFDA-approved and available at all top hospitals (Asan, Samsung, SNU). ~800+ patients treated. ORR: 85–90% for B-cell NHL, 75–80% for B-ALL, 80–85% for multiple myeloma.
$120,000–$180,000 for CD19 CAR-T, $100,000–$150,000 for BCMA CAR-T. 60–70% cheaper than US ($350,000–$500,000). 2–3x more expensive than China ($50,000–$100,000).
3–5 weeks total (from contact to infusion). Initial contact (1–2 days), eligibility review (2–3 days), first appointment (1–2 weeks), treatment start (2–4 weeks). 2x faster than US (6–12 weeks).
Asan Hospital (500+ CAR-T, 85–90% ORR for NHL), Samsung Medical (400+ CAR-T, 80–85% ORR for myeloma), SNU Hospital (600+ CAR-T, 75–80% ORR for B-ALL). Choose based on your cancer type.
Yes, medical visa (C-3) required. Processing time: 3–5 days. Required documents: medical letter (from hospital), flight ticket, hotel booking, payment proof, passport (valid 6+ months).
Yes, 60–70% cheaper for CAR-T, 50–60% cheaper for NK cell, 65–75% cheaper for TIL. Total treatment + hotel (4 weeks): Korea $40,000–$80,000, US $120,000–$240,000.
No, Korea is 2–3x more expensive than China. CAR-T: Korea $120,000–$180,000, China $50,000–$100,000. NK cell: Korea $30,000–$50,000, China $15,000–$25,000. But Korea is 2x faster than China for CAR-T.
Yes, Korean hospitals offer telemedicine for initial consultation and follow-up. First appointment can be virtual. Treatment requires in-person. Follow-up can be mixed (telemedicine + in-person).
10. Evidence Sources
Data verified from Korean hospitals, ClinicalTrials.gov, and published studies.
- 1 Asan Hospital CAR-T Outcomes — 500+ CAR-T, 85–90% ORR (NHL), 60–70% cheaper than US
- 2 Yonsei Severance CAR-T Data — 350+ CAR-T, 30–40% ORR (GBM), NK cell 50–60% cheaper
- 3 Korea Cancer Center Trial Data — 200+ CAR-T, 25–35% ORR (GI), solid tumor CAR-T trial
- 4 Samsung Medical Vaccine Data — Personalized vaccine in Phase 1/2 trial, 70–80% cheaper
Ready to Explore Treatment in South Korea?
Submit your case for a free, no-obligation review. Our oncology team will respond within 48 hours with a clear roadmap of your options in Korea.
Free coordination • No patient fees • HIPAA-aligned • 48-hour response